Selective loss of the transforming growth factor-β apoptotic signaling pathway in mutant NRP-154 rat prostatic epithelial cells

Cell Growth and Differentiation

Volumn 11, Issue 1, 2000, Pages 1-10

  Larisch Bloch, Sarit ^a,b   Danielpour, David ^c   Roche, Nanette S ^a   Lotan, Rona ^b   Hsing, Andrew Y ^a   Kerner, Hedviga ^b   Hajouj, Taleb ^b   Lechleider, Robert J ^a,d   Roberts, Anita B ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b RAMBAM MEDICAL CENTER   (Israel)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTS PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN; PROTEIN BCL X; SEPTIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL GROWTH; CELL MUTANT; CONTROLLED STUDY; MALE; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROSTATE EPITHELIUM; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; RECEPTOR DENSITY; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; BCL-X PROTEIN; CELL DIVISION; IN SITU NICK-END LABELING; MALE; MUTAGENESIS, INSERTIONAL; OKADAIC ACID; PROSTATE; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RETROVIRIDAE; RNA, MESSENGER; SIGNAL TRANSDUCTION; STAUROSPORINE; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0033974321     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (68)

1. Roberts, A. B., and Sporn, M. B. The transforming growth factor-β. In: M. B. Sporn and A. B. Roberts (eds.), Handbook of Experimental Pharmacology: Peptide Growth Factors and Their Receptors, pp. 419-472. Heidelberg: Springer-Verlag, 1990.
2. Heldin, C. H., Miyazono, K., and ten Dijke, P. TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature (Lond.), 390; 465-471, 1997.
3. Kretzschmar, M., and Massagué, J. SMADs: mediators and regulators of TGF-β signaling. Curr. Opin. Genet. Dev., 8: 103-111, 1998.
4. Hartsough, M. T., and Mulder, K. M. Transforming growth factor-β signaling in epithelial cells. Pharmacol. Ther., 75: 21-41, 1997.
5. Frey, R. S., and Mulder, K. M. Involvement of extracellular signal-regulated kinase 2 and stress-activated protein kinase/Jun N-terminal kinase activation by transforming growth factor-β in the negative growth control of breast cancer cells. Cancer Res., 57: 628-633, 1997.
6. Hartsough, M. T., and Mulder, K. M. Transforming growth factor-β activation of p44MAPK in proliferating cultures of epithelial cells. J. Biol. Chem., 270: 7117-7124, 1995.
7. Shibuya, H., Yamaguchi, K., Shirakabe, K., Tonegawa, A., Gotoh, Y., Ueno, N., Irie, K., Nishida, E., and Matsumoto, K. TAB1: an activator of the TAK1 MAPKKK in TGF-β signal transduction. Science (Washington DC), 272: 1179-1182, 1996.
8. Hocevar, B. A., Brown, T. L., and Howe, P. H. TGF-β induces fibronectin synthesis through ac-Jun N-terminal kinase-dependent, Smad4-independent pathway. EMBO J., 18: 1345-1356, 1999.
9. Kretschmar, M., Doody, J., and Massagué, J. Opposing BMP and EGF signaling pathways converge on the TGF-β family mediator Smad1. Nature (Lond.), 389: 618-922, 1997.
10. de Caestecker, M. P., Parks, W. T., Frank, C. J., Castagnino, P., Bottaro, D. P., Roberts, A. B., and Lechleider, R. J. Smad2 transduces common signals from receptor serine-threonine and tyrosine kinases. Genes Dev., 12: 1587-1592, 1998.
11. Kretzschmar, M., Doody, J., Timokhina, I., and Massagué, J. A. mechanism of repression of TGFβ/Smad signaling by oncogenic Ras. Genes Dev., 13: 804-816, 1999.
12. Zhou, S., Buckhaults, P., Zawel, L., Bunz, F., Riggins, G., Le Dai, J., Kern, S. E., Kinzler, K. W., and Vogelstein, B. Targeted deletion of Smad4 shows it is required for transforming growth factor-β and activin signaling in colorectal cancer cells. Proc. Natl. Acad. Sci. USA, 95: 2412-2416, 1998.
13. de Caestecker, M. P., Hemmati, P., Larisch-Bloch, S., Ajmera, R., Roberts, A. B., and Lechleider, R. J. Characterization of functional domains within Smad4/DPC4. J. Biol. Chem., 272: 13690-13696, 1997.
14. Dai, J. L., Schutte, M., Bansal, R. K., Wilentz, R. E., Sugar, A. Y., and Kern, S. E. Transforming growth factor-β responsiveness in DPC4/ SMAD4-null cancer cells. Mol. Carcinog., 26: 37-43, 1999.
15. Atfi, A., Buisine, M., Mazars, A., and Gespach, C. Induction of apoptosis by DPC4, a transcriptional factor regulated by transforming growth factor-β through stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) signaling pathway. J. Biol. Chem., 272: 24731-24734, 1997.
16. Rotello, R. J., Leibermann, R. C., Purchio, A. F., and Gerschenson, L. Coordinated regulation of apoptosis and cell proliferation by transforming growth factor-β1 in cultured uterine epithelial cells. Proc. Natl. Acad. Sci. USA, 88: 3412-3415, 1991.
17. Lin, J. K., and Chou, C. K. In vitro apoptosis in the human hepatoma cell line induced by transforming growth factor β1. Cancer Res., 52: 385-388, 1992.
18. Yanagihara, K., and Tsumuraya, M. Transforming growth factor-β1 induces apoptotic cell death in cultured human gastric carcinoma cells. Cancer Res., 52: 4042-4045, 1992.
19. Saltzman, A., Munro, R., Searfoss, G., Franks, C., Jaye, M., and Ivashchenko, Y. Transforming growth factor-β-mediated apoptosis in the Ramos B-lymphoma cell line is accompanied by caspase activation and Bcl-xL downregulation. Exp. Cell Res., 242: 244-254, 1998.
20. Prehn, J. H. M., Bindokas, V. P., Marcuccilli, C. J., Krajewski, S., Reed, J. C., and Miller, R. J. Regulation of neuronal Bcl2 protein expression and calcium homeostasis by transforming growth factor type β confers wide-ranging protection on rat hippocampal neurons. Proc. Natl. Acad. Sci. USA, 97: 12599-12603, 1994.
21. Ren, R. F., Hawver, D. B., Kim, R. S., and Flanders, K. C. Transforming growth factor-β protects human hNT cells from degeneration induced by β-amyloid peptide: involvement of the TGf-β type II receptor. Brain Res. Mol. Brain Res., 48: 315-322, 1997.
22. Nass, S. J., Li, M., Amundadottir, L. Ts, Furth, P. A., and Dickson, R. B. Role for Bcl-xL in the regulation of apoptosis by EGF and TGF-β1 in c-myc overexpressing mammary epithelial cells. Biochem. Biophys. Res. Commun., 227: 248-256, 1996.
23. Yamamoto, M., Fukuda, K., Miura, N., Suzuki, R., Kido, T., and Komatsu, Y. Inhibition by dexamethasone of transforming growth factor β1-induced apoptosis in rat hepatoma cells: a possible association with Bcl-xL induction. Hepatology, 27: 959-966, 1998.
24. Danielpour, D., Kadomatsu, K., Anzano, M. A., Smith, J. M., and Sporn, M. B. Development and characterization of nontumorigenic and tumorigenic epithelial cells lines from rat dorsal-lateral prostate. Cancer Res., 54: 3413-3421, 1994.
25. Hsing, A. Y., Kadomatsu, K., Bonham, M. J., and Danielpour, D. Regulation of apoptosis induced by transforming growth factor-β1 in nontumorigenic and tumorigenic rat prostatic epithelial cell lines. Cancer Res., 56: 5146-5149, 1996.
26. Wrana, J. L., Attisano, L., Carcamo, J., Zentella, A., Doody, J., Laiho, M., Wang, X. F., and Massagué, J. TGF-β signals through a heteromeric protein kinase receptor complex. Cell, 71: 1003-1014, 1992.
27. Danielpour, D. Induction of transforming growth factor-β autocrine activity by all-rrans-retinoic acid and 1α,25-dihydroxyvitamin D3 in NRP-152 rat prostatic epithelial cells. J. Cell. Physiol., 166: 231-239, 1996.
28. Keeton, M. R., Curriden, S. A., van Zonneveld, A. J., and Loskutoff, D. J. Identification of regulatory sequences in the type 1 plasminogen activator inhibitor gene responsive to transforming growth factor β. J. Biol. Chem., 266: 23048-23052, 1991.
29. Stroschein, S. L., Wang, W., and Luo, K. Cooperative binding of Smad proteins to two adjacent DNA elements in the plasminogen activator inhibitor-1 promoter mediates transforming growth factor β-induced smad-dependent transcriptional activation. J. Biol. Chem., 274: 9431-9441, 1999.
30. Song, C. Z., Siok, T. E., and Gelehrter, T. D. Smad4/DPC4 and Smad3 mediate transforming growth factor-β (TGF-β) signaling through direct binding to a novel TGF-β-responsive element in the human plasminogen activator inhibitor-1 promoter. J. Biol. Chem., 273: 29287-29290, 1998.
31. Hua, X., Liu, X., Ansari, D. O., and Lodish, H. F. Synergistic cooperation of TFE3 and smad proteins in TGF-β-induced transcription of the plasminogen activator inhibitor-1 gene. Genes Dev., 12: 3084-3095, 1998.
32. Bertrand, R., Solary, E., O'Connor, P., Kohn, K. W., and Pommier, Y. Induction of a common pathway of apoptosis by staurosporine. Exp. Cell Res., 211: 314-321, 1994.
33. Krohn, A. J., Preis, E., and Prehn, J. H. Staurosporine-induced apoptosis of cultured rat hippocampal neurons involves caspase-1-like proteases as upstream initiators and increased production of superoxide as a main downstream effector. J. Neurosci., 18: 8186-8197, 1998.
34. Yue, T. L., Wang, C., Romanic, A. M., Kikly, K., Keller, P., DeWolf, W. E., Jr., Hart, T. K., Thomas, H. C., Storer, B., Gu, J. L., Wang, X., and Feuerstein, G. Z. Staurosporine-induced apoptosis in cardiomyocytes: a potential role of caspase-3. J. Mol. Cell. Cardiol., 30: 495-507, 1998.
35. Benito, A., Lerga, A., Silva, M., Leon, J., and Fernandez-Luna, J. L. Apoptosis of human myeloid leukemia cells induced by an inhibitor of protein phosphatases (okadaic acid) is prevented by Bcl-2 and Bcl-X(L). Leukemia (Baltimore), 11: 940-944, 1997.
36. King, K. L., and Cidlowski, J. A. Cell cycle regulation and apoptosis. Annu. Rev. Physiol., 60: 601-617, 1998.
37. Feng, X-H., Filvaroff, E. H., and Derynck, R. Transforming growth factor-β (TGF-β)-induced down-regulation of cyclin A expression requires a functional TGF-β receptor complex. J. Biol. Chem., 270: 24237-24245, 1995.
38. Wakefield, L. M., Letterio, J. J., Geiser, A. G., Flanders, K. C., O'Shaughnessy, J., Roberts, A. B., and Sporn, M. B. Transforming growth factor-βs in mammary tumorigenesis: promoters or antipromoters? Prog. Clin. Biol. Res., 391: 133-148, 1995.
39. Reiss, M. Transforming growth factor-β and cancer: a love-hate relationship? Oncol. Res., 9: 447-457, 1997.
40. Markowitz, S. D., and Roberts, A. B. Tumor suppressor activity of the TGF-β pathway in human cancers. Cytokine Growth Factor Rev., 7: 93-102, 1996.
41. Williams, R. H., Stapleton, A. M. F., Yang, G., Truong, L. D., Rogers, E., Timme, T. L., Wheeler, T. M., Scardino, P. T., and Thompson, T. C. Reduced levels of transforming growth factor β receptor type II in human prostate cancer: an immunohistochemical study. Clin. Cancer Res., 2: 635-640, 1996.
42. Knaus, P. I., Lindemann, D., DeCoteau, J. F., Perlman, R., Yankelev, H., Hille, M., Kadin, M. E., and Lodish, H. F. A dominant inhibitory mutant of the type II transforming growth factor β receptor in the malignant progression of a cutaneous T-cell lymphoma. Mol. Cell. Biol., 16: 3480-3489, 1996.
43. Kim, I. Y., Ahn, H. J., Zelner, D. J., Shaw, J. W., Sensibar, J. A., Kim, J. H., Kato, M., and Lee, C. Genetic change in transforming growth factor β (TGF-β) receptor type I gene correlates with insensitivity to TGF-β in human prostate cancer cells. Cancer Res., 56: 44-48, 1996.
44. Choi, S. G., Yi, Y., Kim, Y. S., Kato, M., Chang, J., Chung, H. W., Hahm, K. B., Yang, H. K., Rhee, H. H., Bang, Y. J., and Kim, S. J. A novel ets-related transcription factor, ERT/ESX/ESE-1, regulates expression of the transforming growth factor-β type II receptor. J. Biol. Chem., 273: 110-117, 1998.
45. Ammanamanchi, S., Kim, S. J., Sun, L. Z., and Brattain, M. G. Induction of transforming growth factor-β receptor type II expression in estrogen receptor-positive breast cancer cells through SP1 activation by 5-aza-2′-deoxycytidine. J. Biol. Chem., 273: 16527-16534, 1998.
46. Moskaluk, C. A., and Kern, S. E. Cancer gets Mad: DPC4 and other TGF-β pathway genes in human cancer. Biochim. Biophys. Acta, 1288: M31-M33, 1996.
47. Eppert, K., Scherer, S. W., Ozcelik, H., Pirone, R., Hoodless, P., Kim, H., Tsui, L. C., Bapat, B., Gallinger, S., Andrulis, I. L., Thomsen, G. H., Wrana, J. L., and Attisano, L. MADR2 maps to 18q21 and encodes a TGF-β-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell, 86: 543-552, 1996.
48. Hahn, S. A., Schutte, M., Hoque, A. T., Moskaluk, C. A., da Costa, L. T., Rozenblum, E., Weinstein, C. L., Fischer, A., Yeo, C. J., Hruban, R. H., and Kern, S. E. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science (Washington DC), 271: 350-353, 1996.
49. Schutte, M., Hruban, R. H., Hedrick, L., Cho, K. R., Nadasdy, G. M., Weinstein, C. L., Bova, G. S., Isaacs, W. B., Cairns, P., Nawroz, H., Sidransky, D., Casero, R. A., Jr., Meltzer, P. S., Hahn, S. A., and Kern, S. E. DPC4 gene in various tumor types. Cancer Res., 56: 2527-2530, 1996.
50. Nagatake, M., Takagi, Y., Osada, H., Uchida, K., Mitsudomi, T., Saji, S., Shimokata, K., Takahashi, T., and Takahashi, T. Somatic in vivo alterations of the DPC4 gene at 18q21 in human lung cancers. Cancer Res., 56: 2718-2720, 1996.
51. Knudson, A. G., Jr. Hereditary cancer, oncogenes, and antioncogenes. Cancer Res., 45: 1437-1443, 1985.
52. Chen, R. H., Ebner, R., and Derynck, R. Inactivation of the type II receptor reveals two receptor pathways for the diverse TGF-β activities. Science (Washington DC), 260: 1335-1338, 1993.
53. McCaffrey, T. A., Consigli, S., Du, B., Falcone, D. J., Sanborn, T. A., Spokojny, A. M., and Bush, H. L., Jr. Decreased type II/type I TGF-β receptor ratio in cells derived from human atherosclerotic lesions. Conversion from an antiproliferative to profibrotic response to TGF-β1. J. Clin. Investig., 96: 2667-2675, 1995.
54. Sankar, S., Mahooti-Brooks, N., Bensen, L., McCarthy, T. L., Centrella, M., and Madri, J. A. Modulation of transforming growth factor-β receptor levels on microvascular endothelial cells during in vitro angiogenesis. J. Clin. Investig., 97: 1436-1446, 1996.
55. Souchelnytskyi, S., ten Dijke, P., Miyazono, K., and Heldin, C. H. Phosphorylation of Ser165 in TGF-β type I receptor modulates TGF-β1-induced cellular responses. EMBO J., 15: 6231-6240, 1996.
56. Tang, B., de Castro, K., Barnes, H. E., Parks, W. T., Stewart, L., Böttinger, E. P., Danielpour, D., and Wakefield, L. M. Loss of responsiveness to transforming growth factor β induces malignant transformation of nontumorigenic rat prostate epithelial cells. Cancer Res., 59: 4834-4842, 1999.
57. Green, D. R., and Reed, J. C. Mitochondria and apoptosis. Science (Washington DC), 281, 1309-1312, 1998.
58. Gross, A., McDonnell, J. M., and Korsmeyer, S. J. BCL-2 family members and the mitochondria in apoptosis. Genes Dev., 13: 1899-1911, 1999.
59. Reed, J. C., Jurgensmeier, J. M., and Matsuyama, S. Bcl-2 family proteins and mitochondria. Biochim. Biophys. Acta, 1366: 127-137, 1998.
60. Zamzami, N., Brenner, C., Marzo, I., Susin, S. A., and Kroemer, G. Subcellular and submitochondrial mode of action of Bcl-2-like oncoproteins. Oncogene, 16: 2265-2282, 1998.
61. Aravind, L., Dixit, V. M., and Koonin, E. V. The domains of death: evolution of the apoptotic machinery. Trends Biochem. Sci., 24: 47-53, 1999.
62. Saraste, M., Sibbald, P. R., and Wittinghofer A. The P-loop-a common motif in ATP- and GTP-binding proteins. Trends Biochem. Sci., 11: 430-434, 1990.
63. Chaudhary, D., O'Rourke, K., Chinnaiyan, A. M., and Dixit, V. M. The death inhibitory molecules CED-9 and CED-4L use a common mechanism to inhibit the CED-3 death protease. J. Biol. Chem., 273: 17708-17712, 1998.
64. Hu, Y., Benedict, M. A., Ding., L., and Núñez, G. Role of cytochrome c and dATP/ATP hydrolysis in Apaf-1-mediated caspase-9 activation and apoptosis. EMBO J., 18: 3586-3595, 1999.
65. Kyprianou, N., and Isaacs, J. T. Expression of transforming growth factor-β in the rat ventral prostate during castration-induced programmed cell death. Mol. Endocrinol., 3: 1515-1522, 1989.
66. Guo, Y., and Kyprianou, N. Restoration of transforming growth factor β signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis. Cancer Res., 59: 1366-1371, 1999.
67. Rajah, R., Valentinis, B., and Cohen, P. Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-β1 on programmed cell death through a p53- and IGF-independent mechanism. J. Biol. Chem., 272: 12181-12188. 1997.
68. Roberson, K. M., Penland, S. N., Padilla, G. M., Selvan, R. S., Kim, C. S., Fine, R. L., and Robertson, C. N. Fenretinide: induction of apoptosis and endogenous transforming growth factor β in PC-3 prostate cancer cells. Cell Growth Differ., 8: 101-111, 1997.